Summary First-Mover Advantage: Soleno has the market to itself until competition intensifies. High Sales Potential: Projected sales of $876 million…
Read More »Soleno Therapeutics
Despite weak economic data, the S&P 500 (SPX) closed higher to start the new quarter as traders awaited President Donald…
Read More »